U. Havemann

789 total citations
31 papers, 629 citations indexed

About

U. Havemann is a scholar working on Cellular and Molecular Neuroscience, Physiology and Molecular Biology. According to data from OpenAlex, U. Havemann has authored 31 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cellular and Molecular Neuroscience, 20 papers in Physiology and 14 papers in Molecular Biology. Recurrent topics in U. Havemann's work include Neurotransmitter Receptor Influence on Behavior (21 papers), Pain Mechanisms and Treatments (20 papers) and Neuropeptides and Animal Physiology (12 papers). U. Havemann is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (21 papers), Pain Mechanisms and Treatments (20 papers) and Neuropeptides and Animal Physiology (12 papers). U. Havemann collaborates with scholars based in Germany, Poland and Czechia. U. Havemann's co-authors include K. Kuschinsky, M. Winkler, Lechosław Turski, L. Turski, Michael Schwarz, J Vetulani, E. Genç, Michael Schwarz, Lucyna Antkiewicz‐Michaluk and Anton Wellstein and has published in prestigious journals such as Brain Research, Life Sciences and Psychopharmacology.

In The Last Decade

U. Havemann

31 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U. Havemann Germany 15 493 305 216 85 58 31 629
A. Ableitner Germany 10 656 1.3× 366 1.2× 402 1.9× 35 0.4× 130 2.2× 14 918
G. Stock Germany 11 380 0.8× 230 0.8× 102 0.5× 36 0.4× 120 2.1× 22 587
Eagle Yi‐Kung Huang Taiwan 17 375 0.8× 226 0.7× 192 0.9× 61 0.7× 55 0.9× 47 638
Susan Punnen United States 10 338 0.7× 223 0.7× 136 0.6× 24 0.3× 52 0.9× 11 639
Carla G. Cardenas United States 11 387 0.8× 423 1.4× 379 1.8× 63 0.7× 50 0.9× 12 692
C. Y. Chai Taiwan 12 191 0.4× 103 0.3× 178 0.8× 20 0.2× 47 0.8× 39 548
Lowell A. Roberts United States 8 275 0.6× 115 0.4× 223 1.0× 26 0.3× 111 1.9× 8 473
Takahiko Tanaka Japan 13 366 0.7× 183 0.6× 69 0.3× 87 1.0× 74 1.3× 19 581
Masayoshi Tsuruoka Japan 16 251 0.5× 101 0.3× 499 2.3× 64 0.8× 110 1.9× 45 629
Syogoro Nishi Japan 11 355 0.7× 252 0.8× 125 0.6× 30 0.4× 80 1.4× 38 475

Countries citing papers authored by U. Havemann

Since Specialization
Citations

This map shows the geographic impact of U. Havemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Havemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Havemann more than expected).

Fields of papers citing papers by U. Havemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Havemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Havemann. The network helps show where U. Havemann may publish in the future.

Co-authorship network of co-authors of U. Havemann

This figure shows the co-authorship network connecting the top 25 collaborators of U. Havemann. A scholar is included among the top collaborators of U. Havemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Havemann. U. Havemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Havemann, U., et al.. (1986). On the mechanisms of the development of tolerance to the muscular rigidity produced by morphine in rats. European Journal of Pharmacology. 129(3). 315–321. 3 indexed citations
3.
Havemann, U., et al.. (1986). Individual and morphological differences in the behavioural response to apomorphine in rats. Psychopharmacology. 90(1). 40–8. 40 indexed citations
4.
Havemann, U., et al.. (1985). Pharmacokinetics of morphine in striatum and nucleus accumbens: Relationship to pharmacological actions. Pharmacology Biochemistry and Behavior. 23(2). 295–301. 19 indexed citations
5.
Turski, Lechosław, U. Havemann, & K. Kuschinsky. (1984). Role of muscarinic cholinergic mechanisms in the substantia nigra pars reticulata in mediating muscular rigidity in rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 327(1). 14–17. 9 indexed citations
6.
Turski, L., U. Havemann, & K. Kuschinsky. (1984). GABAergic mechanisms in mediating muscular rigidity, catalepsy and postural asymmetry in rats: Differences between dorsal and ventral striatum. Brain Research. 322(1). 49–57. 52 indexed citations
7.
Havemann, U., M. Winkler, & K. Kuschinsky. (1983). The effects of D-ala2, D-leu5-enkephalin injections into the nucleus accumbens on the motility of rats. Life Sciences. 33. 627–630. 17 indexed citations
8.
Havemann, U. & K. Kuschinsky. (1982). Neurochemical aspects of the opioid-induced ‘catatonia’. Neurochemistry International. 4(4). 199–215. 54 indexed citations
9.
Havemann, U., Lechosław Turski, & K. Kuschinsky. (1982). Role of GABAergic mechanisms in the substantia nigra pars reticulata in modulating morphine-induced muscular rigidity in rats. Neuroscience Letters. 31(1). 25–30. 14 indexed citations
10.
Turski, Lechosław, U. Havemann, & K. Kuschinsky. (1982). Evidence that opioid receptors in the substantia nigra pars reticulata are relevant in regulating the function of striatal efferent pathways. Behavioural Brain Research. 5(4). 415–422. 9 indexed citations
11.
Havemann, U., M. Winkler, & K. Kuschinsky. (1982). Is morphine-induced akinesia related to inhibition of reflex activation of flexor ?-motoneurones?. Naunyn-Schmiedeberg s Archives of Pharmacology. 320(2). 101–104. 6 indexed citations
12.
Turski, Lechosław, U. Havemann, & K. Kuschinsky. (1982). On the possible role of excitatory amino acids in the striatum in mediating morphine-induced muscular rigidity. Pharmacology Biochemistry and Behavior. 17(4). 715–719. 9 indexed citations
13.
Winkler, M., U. Havemann, & K. Kuschinsky. (1982). Unilateral injection of morphine into the nucleus accumbens induces akinesia and catalepsy, but no spontaneous muscular rigidity in rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 318(3). 143–147. 43 indexed citations
14.
Turski, Lechosław, U. Havemann, Michael Schwarz, & K. Kuschinsky. (1982). Disinhibition of nigral GABA output neurons mediates muscular rigidity elicited by striatal opioid receptor stimulation. Life Sciences. 31(20-21). 2327–2330. 16 indexed citations
15.
Havemann, U., et al.. (1981). Effects of striatal lesions with kainic acid on morphine-induced ?catatonia? and increase of striatal dopamine turnover. Naunyn-Schmiedeberg s Archives of Pharmacology. 317(1). 44–50. 25 indexed citations
16.
Havemann, U., M. Winkler, & K. Kuschinsky. (1980). Opioid receptors in the caudate nucleus can mediate EMG-recorded rigidity in rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 313(2). 139–144. 59 indexed citations
17.
Havemann, U., M. Winkler, E. Genç, & K. Kuschinsky. (1980). Opioid actions on motility: Possible actions on GABA-ergic and dopaminergic neurons. Brain Research Bulletin. 5. 891–896. 8 indexed citations
18.
Havemann, U. & K. Kuschinsky. (1978). Interactions of opiates and prostaglandins E with regard to cyclic AMP in striatal tissue of rats in vitro. Naunyn-Schmiedeberg s Archives of Pharmacology. 302(1). 103–106. 13 indexed citations
19.
Havemann, U. & K. Kuschinsky. (1978). Effects of Opiates on cAMP in Homogenates and Slices of Rat Striata. Pharmacology. 16(5). 295–299. 11 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Ableitner Breakdown of academic impact, for papers by G. Stock Breakdown of academic impact, for papers by Eagle Yi‐Kung Huang Breakdown of academic impact, for papers by Susan Punnen Breakdown of academic impact, for papers by Carla G. Cardenas Breakdown of academic impact, for papers by C. Y. Chai Breakdown of academic impact, for papers by Lowell A. Roberts Breakdown of academic impact, for papers by Takahiko Tanaka Breakdown of academic impact, for papers by Masayoshi Tsuruoka Breakdown of academic impact, for papers by Syogoro Nishi
Rankless by CCL
2026